Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04770571

Posterior Cervical Fixation Study

A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
NuVasive · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and performance of occipito-cervico-thoracic spine surgery using posterior fixation as measured by reported complications, radiographic outcomes, and patients reported outcomes (PROs).This study is being undertaken to identify possible residual risks and to clarify mid-to long-term clinical performance that may affect the benefit/risk ratio of posterior fixation systems.

Detailed description

This study is a prospective, uncontrolled, multicenter study to evaluate the safety and performance of select occipito-cervico-thoracic posterior fixation systems in patients who undergo posterior fixation fusion surgery. Consecutive patients at a given site who meet eligibility requirements will be asked to consent to participate in the study. These patients will present with traumatic, reconstructive, and/or tumor conditions in the craniocervical, cervical, and/or upper thoracic spine that are amenable to surgical treatment and will be screened prior to study enrollment. Once enrolled in the study, subjects will undergo posterior occipito-cervico-thoracic fixation surgery using one of the NuVasive posterior fixation systems (Vuepoint II OCT or Reline-C) based on the surgeon's standard of care. At least 150 subjects (a minimum of 75 in each implant arm) will be enrolled and will be followed for 24 months after the surgery.

Conditions

Interventions

TypeNameDescription
DEVICEobservational studyobservational

Timeline

Start date
2022-05-10
Primary completion
2026-09-01
Completion
2028-11-01
First posted
2021-02-25
Last updated
2025-12-22

Locations

7 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04770571. Inclusion in this directory is not an endorsement.